contrast media

Preferred Label : contrast media;

MeSH definition : Substances used to allow enhanced visualization of tissues.;

MeSH synonym : agents, contrast; materials, contrast; contrast agents; media, contrast; contrast materials; Contrast Agent; Agent, Contrast; Contrast Material; Material, Contrast;

MeSH hyponym : radiocontrast media; Media, Radiocontrast; Radiocontrast Agent; Agent, Radiocontrast; Radiocontrast Agents; Agents, Radiocontrast; Radiopaque Media; Media, Radiopaque;

MeSH annotation : /adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS;

Wikipedia link : https://en.wikipedia.org/wiki/Contrast agent;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D003287;

UMLS CUI

C0009924;

ATC code(s)
- barium sulfate without suspending agents [ATC Code]
- contrast media [ATC Code]
- microparticles of galactose [ATC Code]
- perflutren, human albumin microspheres [ATC Code]
- perflutren, phospholipid microspheres [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Contractual Agreement [NCIt concept]
- Contrast [LOINC part]
- Contrast media [ICD-11 Extension code]
- Contrast media (substance) [SNOMED CT concept]
- PDC Gene [NCIt concept]
- Paroxysmal nonkinesigenic dyskinesia 1 [OMIM Phenotype]
- Phosducin [OMIM gene]
- Phosducin [NCIt concept]
- Radiation, not otherwise specified [ICHI means]
- Radiographic contrast media (product) [SNOMED CT concept]
- Total Clearance Observed for Unbound Drug [NCIt concept]
- contrast agent [Radlex concept]
- radiographic contrast media, nos [SNOMED Notion]
- radiopaque medium, nos [SNOMED Notion]
CISMeF manual mappings
- Contrast media poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Contrast Agent [NCIt concept]
- Contrast media (product) [SNOMED CT concept]
- contrast media [ATC Code]
Indexing information
- (5,10,15,20-tetrakis(carboxy)porphyrinato)manganese(III) [MeSH Supplementary Concept]
- 1,1'-bis-(4-sulfobutyl)indotricarbocyanine-5,5'-dicarboxylic acid diglucamide [MeSH Supplementary Concept]
- 1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrole-3-carboxylic acid [MeSH Supplementary Concept]
- 111-indium-ethylenediaminetetracetic acid-biotin [MeSH Supplementary Concept]
- 4,4'-bis(manganese(III) 5,10,15-tris(4-sulfonatophenyl)porphin-20-yl)biphenyl [MeSH Supplementary Concept]
- AMI-HS cpd [MeSH Supplementary Concept]
- B-22956-1 [MeSH Supplementary Concept]
- CEIV-7 [MeSH Supplementary Concept]
- CT 345 [MeSH Supplementary Concept]
- CT 346 [MeSH Supplementary Concept]
- ECIII-60 [MeSH Supplementary Concept]
- EP-2104R [MeSH Supplementary Concept]
- EZ-HD [MeSH Supplementary Concept]
- LUF [MeSH Supplementary Concept]
- MRX 501 [MeSH Supplementary Concept]
- P743 [MeSH Supplementary Concept]
- SH U 563 A [MeSH Supplementary Concept]
- SHH340AB [MeSH Supplementary Concept]
- ST68 [MeSH Supplementary Concept]
- barytgen [MeSH Supplementary Concept]
- bis((bis(carboxymethyl)amino)methyl)phosphinate [MeSH Supplementary Concept]
- ethiotrast [MeSH Supplementary Concept]
- gadolinium diethylene-triamine-pentaacetic acid-bis-oleate [MeSH Supplementary Concept]
- gadolinium-1-(2-difluoromethyl-4-(1-(4,7,10-triscarboxymethyl(1,4,7,10-tetraazacyclodecyl))acetamido)phenyl)glucopyronuronate [MeSH Supplementary Concept]
- gadomer 17 [MeSH Supplementary Concept]
- gastroluft [MeSH Supplementary Concept]
- lumagel [MeSH Supplementary Concept]
- manganese-hydroxypropyl-tetraacetic acid [MeSH Supplementary Concept]
- micropack N.D. [MeSH Supplementary Concept]
- monocrystalline iron oxide nanoparticle [MeSH Supplementary Concept]
- onyx 18 [MeSH Supplementary Concept]
- poly(lactic acid)-b-poly(sarcosine) [MeSH Supplementary Concept]
- ronpacon cerebral 280 [MeSH Supplementary Concept]
- sterofundin [MeSH Supplementary Concept]
- technetium 99m cys-annexin A5 [MeSH Supplementary Concept]
- zarvin protein [MeSH Supplementary Concept]
- zinc chromium ferrite [MeSH Supplementary Concept]
Metaterm(s)
- medical imaging [CISMeF Metaterm]
Record concept(s)
- contrast media [MeSH concept]
- radiocontrast media [MeSH concept]
See also
- extravasation of diagnostic and therapeutic materials [MeSH Descriptor]
- radiography [MeSH Descriptor]
See also inter- (CISMeF)
- diffuse contrast enhancement [SYNODOS term]
- heterogeneous contrast enhancement [SYNODOS term]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
Substance(s)
- 3-hydroxyephedrine [MeSH Supplementary Concept]
- 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide [MeSH Supplementary Concept]
- 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole [MeSH Supplementary Concept]
- BR14 contrast agent [MeSH Supplementary Concept]
- BY 963 [MeSH Supplementary Concept]
- C.I. Fluorescent Brightening Agent 28 [MeSH Supplementary Concept]
- FS 069 [MeSH Supplementary Concept]
- Metrizoic Acid [MeSH Descriptor]
- Mn-PyC3A [MeSH Supplementary Concept]
- N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid [MeSH Supplementary Concept]
- SHU 454 [MeSH Supplementary Concept]
- SHU 508 [MeSH Supplementary Concept]
- acetrizoic acid [MeSH Descriptor]
- albumin-(gadolinium-DTPA) [MeSH Supplementary Concept]
- albunex [MeSH Supplementary Concept]
- altanserin [MeSH Supplementary Concept]
- barium fluoride [MeSH Supplementary Concept]
- barium sulfate [MeSH Descriptor]
- diatrizoate [MeSH Descriptor]
- diatrizoate meglumine [MeSH Descriptor]
- diethylenetriamine pentaacetic acid dianhydride [MeSH Supplementary Concept]
- epidepride [MeSH Supplementary Concept]
- ethiodized oil [MeSH Descriptor]
- ferrioxamine B [MeSH Supplementary Concept]
- ferumoxides [MeSH Supplementary Concept]
- ferumoxtran-10 [MeSH Supplementary Concept]
- fluorescein [MeSH Descriptor]
- flutemetamol [MeSH Supplementary Concept]
- gadobenic acid [MeSH Supplementary Concept]
- gadobutrol [MeSH Supplementary Concept]
- gadodiamide [MeSH Supplementary Concept]
- gadofosveset trisodium [MeSH Supplementary Concept]
- gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate [MeSH Supplementary Concept]
- gadolinium DTPA [MeSH Descriptor]
- gadolinium chloride [MeSH Supplementary Concept]
- gadolinium ethoxybenzyl DTPA [MeSH Supplementary Concept]
- gadoterate meglumine [MeSH Supplementary Concept]
- gadoteridol [MeSH Supplementary Concept]
- gadoversetamide [MeSH Supplementary Concept]
- glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination [MeSH Supplementary Concept]
- iobenzamic acid [MeSH Supplementary Concept]
- iobitridol [MeSH Supplementary Concept]
- iocarmate meglumine [MeSH Supplementary Concept]
- iodamide [MeSH Descriptor]
- iodipamide [MeSH Descriptor]
- iodixanol [MeSH Supplementary Concept]
- iodized oil [MeSH Descriptor]
- iodohippuric acid [MeSH Descriptor]
- iodopyracet [MeSH Descriptor]
- iodoxamic acid [MeSH Supplementary Concept]
- ioglycamic acid [MeSH Descriptor]
- iohexol [MeSH Descriptor]
- iomeprol [MeSH Supplementary Concept]
- iopamidol [MeSH Descriptor]
- iopanoic acid [MeSH Descriptor]
- iopentol [MeSH Supplementary Concept]
- iophendylate [MeSH Descriptor]
- iopromide [MeSH Supplementary Concept]
- iothalamate meglumine [MeSH Descriptor]
- iothalamic acid [MeSH Descriptor]
- iotrolan [MeSH Supplementary Concept]
- ioversol [MeSH Supplementary Concept]
- ioxaglic acid [MeSH Descriptor]
- ioxilan [MeSH Supplementary Concept]
- ioxitalamic acid [MeSH Supplementary Concept]
- ipodate [MeSH Descriptor]
- magnetite nanoparticles [MeSH Descriptor]
- manganese(III)tetraphenylporphine sulfonate [MeSH Supplementary Concept]
- meglumine [MeSH Descriptor]
- meglumine iodipamide [MeSH Supplementary Concept]
- meglumine iotroxinate [MeSH Supplementary Concept]
- meglumine ioxithalamate [MeSH Supplementary Concept]
- metrizamide [MeSH Descriptor]
- motexafin gadolinium [MeSH Supplementary Concept]
- oxypolygelatine [MeSH Supplementary Concept]
- perflubron [MeSH Supplementary Concept]
- perfluoropentane [MeSH Supplementary Concept]
- perfluorophenanthrene [MeSH Supplementary Concept]
- perflutren [MeSH Supplementary Concept]
- poly-gamma-benzyl-L-glutamate [MeSH Supplementary Concept]
- polylysine-(Gd-DTPA) [MeSH Supplementary Concept]
- propyliodone [MeSH Descriptor]
- setoperone [MeSH Supplementary Concept]
- sonazoid [MeSH Supplementary Concept]
- sprodiamide [MeSH Supplementary Concept]
- tetraphenylporphine sulfonate [MeSH Supplementary Concept]
- tozuleristide [MeSH Supplementary Concept]
- tyropanoate [MeSH Descriptor]
- urovision [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Contrast [LOINC part]
- Contrast Agent [NCIt concept]
- Contrast media (product) [SNOMED CT concept]
- Contrast media (substance) [SNOMED CT concept]
- contrast media [ATC Code]
Validated automatic mappings to BTNT
- X-ray contrast media, iodinated [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients